Who owns Sarepta Therapeutics note 1.500% 11/1?
- CUSIP Number: 803607ab6
Tip: Access positions for across all investors
Analyze quarterly positions in Sarepta Therapeutics note 1.500% 11/1 with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Sarepta Therapeutics note 1.500% 11/1 stock
Who bought or sold Sarepta Therapeutics note 1.500% 11/1 this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| DLD Asset Management | 15M | $21M | 41% | Dec 2023 |
|
| Point72 Asset Management | 14M | $20M | 58% | Dec 2023 |
|
| D. E. Shaw & Co | 11M | $16M | 3% | Dec 2023 |
|
| CSS | 8.2M | $12M | 0% | Dec 2023 |
|
| Capstone Investment Advisors | 5.1M | $7.2M | 0% | Dec 2023 |
|
| Worth Venture Partners | 2.8M | $4.0M | 95% | Dec 2023 |
|
| Bank of America Corporation | 1.3M | $1.9M | -76% | Dec 2023 |
|
| Palisade Capital Management | 1.0M | $1.4M | 0% | Dec 2023 |
|
| Warberg Asset Management | 550k | $781k | 6% | Dec 2023 |
|
| Wolverine Asset Management | 156k | $221k | 100% | Dec 2023 |
|
| Bnp Paribas Arbitrage, Snc | 68k | $96k | 100% | Dec 2023 |
|
| Fox Hill Wealth Management | 24k | $43k | 4% | Mar 2024 |
|
| Virtus Investment Advisers | 4.0k | $5.7k | 100% | Dec 2023 |
|
| Royal Bank of Canada | 2.0k | $3.0k | 0% | Dec 2023 |
|
| Citigroup | 1.0k | $1.4k | -100% | Dec 2023 |
|
| Wells Fargo & Company | 1.0k | $1.3k | 0% | Dec 2023 |
|
Who sold out of Sarepta Therapeutics note 1.500% 11/1?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Tenor Capital Management | Sep 2023 | 5.2M | $9.3B |